IL147201A0 - Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response - Google Patents
Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug responseInfo
- Publication number
- IL147201A0 IL147201A0 IL14720100A IL14720100A IL147201A0 IL 147201 A0 IL147201 A0 IL 147201A0 IL 14720100 A IL14720100 A IL 14720100A IL 14720100 A IL14720100 A IL 14720100A IL 147201 A0 IL147201 A0 IL 147201A0
- Authority
- IL
- Israel
- Prior art keywords
- anticoagulant
- surrogate markers
- patient
- treating
- prevent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Radiation-Therapy Devices (AREA)
- Electrotherapy Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Accommodation For Nursing Or Treatment Tables (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/348,592 US6267116B1 (en) | 1999-07-06 | 1999-07-06 | Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug |
| PCT/US2000/018576 WO2001002050A2 (en) | 1999-07-06 | 2000-07-06 | Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL147201A0 true IL147201A0 (en) | 2002-08-14 |
Family
ID=23368686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14720100A IL147201A0 (en) | 1999-07-06 | 2000-07-06 | Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US6267116B1 (de) |
| EP (1) | EP1191894B1 (de) |
| JP (1) | JP2003503165A (de) |
| KR (1) | KR20020036790A (de) |
| CN (1) | CN1359276A (de) |
| AT (1) | ATE378015T1 (de) |
| AU (1) | AU5919800A (de) |
| BR (1) | BR0012241A (de) |
| CA (1) | CA2362429C (de) |
| DE (1) | DE60037116T2 (de) |
| IL (1) | IL147201A0 (de) |
| MX (1) | MXPA01013306A (de) |
| NO (2) | NO20020043D0 (de) |
| TR (1) | TR200103831T2 (de) |
| WO (1) | WO2001002050A2 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6575169B2 (en) * | 1999-07-06 | 2003-06-10 | The Rxfiles Corporation | Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug |
| US6581607B2 (en) * | 1999-07-06 | 2003-06-24 | The Rx Files Corporation | Method and system for use in treating a patient with a biological substance to optimize therapy and prevent an adverse response |
| US6267116B1 (en) * | 1999-07-06 | 2001-07-31 | The Rxfiles Corporation | Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug |
| US6581606B2 (en) * | 1999-07-06 | 2003-06-24 | The Rx Files Corporation | Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response |
| EP1311202A4 (de) * | 2000-08-24 | 2007-04-18 | Dimensional Dosing Systems Inc | Verfahren und vorrichtung zur revision der antikoagulantdosis |
| US6578582B2 (en) * | 2001-08-24 | 2003-06-17 | The Rxfiles Corporation | Method and apparatus using IDS™ for multi-agent therapy |
| US6883521B2 (en) * | 2001-08-24 | 2005-04-26 | Dimensional Dosing Systems, Inc. | Method and apparatus for dosing single and multi-agent therapy |
| WO2003026727A1 (en) * | 2001-09-28 | 2003-04-03 | Lifevent Limited | sETHOD AND APPARATUS FOR DELIVERY OF MEDICATION |
| US20050154537A1 (en) * | 2003-12-12 | 2005-07-14 | Kutzko John D. | Methods, program products, and systems for single and multi-agent dosing and other related methods |
| PL1862233T3 (pl) * | 2006-06-01 | 2011-07-29 | Wila Bv | Narzędzie z automatycznym zatrzaskiem zabezpieczającym |
| EP1862255B1 (de) * | 2006-06-01 | 2011-03-16 | Wila B.V. | Auswechselbares Werkzeug/Manipulator Kombination |
| US20090216561A1 (en) * | 2008-02-22 | 2009-08-27 | Swedish Health Services | Methods for management of anticoagulation therapy |
| US8112290B2 (en) * | 2008-05-16 | 2012-02-07 | Adolor Corporation | Methods for delivering a drug to a hospital patient for short-term use while minimizing long-term use of the drug |
| ES2927105T3 (es) * | 2008-10-20 | 2022-11-02 | Epitome Pharmaceuticals Ltd | Métodos y sistemas para mejorar la intervención farmacéutica en el control de la coagulación |
| WO2011163506A2 (en) | 2010-06-23 | 2011-12-29 | University Of Louisville Research Foundation, Inc. | Methods and kits for predicting a response to an erythropoietic agent |
| US9852267B2 (en) | 2011-09-30 | 2017-12-26 | University Of Louisville Research Foundation, Inc. | System and method for personalized dosing of pharmacologic agents |
| US10083400B2 (en) | 2012-10-05 | 2018-09-25 | Diane R. MOULD | System and method for providing patient-specific dosing as a function of mathematical models updated to account for an observed patient response |
| AU2016245862A1 (en) | 2015-04-09 | 2018-02-22 | Diane R. Mould | Systems and methods for patient-specific dosing |
| US20190043501A1 (en) * | 2017-08-02 | 2019-02-07 | Elements of Genius, Inc. | Patient-centered assistive system for multi-therapy adherence intervention and care management |
| US12046341B2 (en) * | 2021-10-05 | 2024-07-23 | Bradford Rabin | Methods and systems for electronically adjusting a dosing pattern of a patient undergoing a medical regimen |
| KR20240033436A (ko) | 2022-09-05 | 2024-03-12 | 박세경 | 휴대용 머신러닝 기반의 약물 부작용 탐지 시스템 |
| US12295943B2 (en) | 2023-09-22 | 2025-05-13 | Closed Loop Medicine Ltd | Apixaban dosing |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5694950A (en) * | 1992-08-21 | 1997-12-09 | J & W Mcmichael Software, Inc. | Method and system for use in treating a patient with immunosuppresants using whole blood level criteria to prevent an adverse immune response |
| US5365948A (en) * | 1992-08-21 | 1994-11-22 | J & W Mcmichael Software Inc. | Method for use in treating a patient with FK 506 to prevent an adverse immune response |
| US6581607B2 (en) * | 1999-07-06 | 2003-06-24 | The Rx Files Corporation | Method and system for use in treating a patient with a biological substance to optimize therapy and prevent an adverse response |
| US6581606B2 (en) * | 1999-07-06 | 2003-06-24 | The Rx Files Corporation | Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response |
| US6267116B1 (en) * | 1999-07-06 | 2001-07-31 | The Rxfiles Corporation | Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug |
| US6575169B2 (en) * | 1999-07-06 | 2003-06-10 | The Rxfiles Corporation | Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug |
-
1999
- 1999-07-06 US US09/348,592 patent/US6267116B1/en not_active Expired - Lifetime
-
2000
- 2000-07-06 IL IL14720100A patent/IL147201A0/xx unknown
- 2000-07-06 AU AU59198/00A patent/AU5919800A/en not_active Abandoned
- 2000-07-06 MX MXPA01013306A patent/MXPA01013306A/es not_active Application Discontinuation
- 2000-07-06 JP JP2001507538A patent/JP2003503165A/ja not_active Withdrawn
- 2000-07-06 TR TR2001/03831T patent/TR200103831T2/xx unknown
- 2000-07-06 EP EP00945223A patent/EP1191894B1/de not_active Expired - Lifetime
- 2000-07-06 AT AT00945223T patent/ATE378015T1/de not_active IP Right Cessation
- 2000-07-06 KR KR1020017016623A patent/KR20020036790A/ko not_active Ceased
- 2000-07-06 DE DE60037116T patent/DE60037116T2/de not_active Expired - Lifetime
- 2000-07-06 BR BR0012241-6A patent/BR0012241A/pt not_active Application Discontinuation
- 2000-07-06 CA CA002362429A patent/CA2362429C/en not_active Expired - Fee Related
- 2000-07-06 WO PCT/US2000/018576 patent/WO2001002050A2/en not_active Ceased
- 2000-07-06 CN CN00809908A patent/CN1359276A/zh not_active Withdrawn
- 2000-08-24 US US09/644,503 patent/US6942614B1/en not_active Expired - Fee Related
-
2002
- 2002-01-04 NO NO20020043A patent/NO20020043D0/no unknown
- 2002-01-07 NO NO20020056A patent/NO20020056L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA01013306A (es) | 2002-07-02 |
| NO20020056D0 (no) | 2002-01-07 |
| CN1359276A (zh) | 2002-07-17 |
| US6267116B1 (en) | 2001-07-31 |
| DE60037116T2 (de) | 2008-09-11 |
| JP2003503165A (ja) | 2003-01-28 |
| TR200103831T2 (tr) | 2002-10-21 |
| ATE378015T1 (de) | 2007-11-15 |
| WO2001002050A2 (en) | 2001-01-11 |
| EP1191894A4 (de) | 2004-10-20 |
| NO20020043D0 (no) | 2002-01-04 |
| AU5919800A (en) | 2001-01-22 |
| CA2362429A1 (en) | 2001-01-11 |
| BR0012241A (pt) | 2002-03-26 |
| CA2362429C (en) | 2005-07-05 |
| KR20020036790A (ko) | 2002-05-16 |
| US6942614B1 (en) | 2005-09-13 |
| EP1191894A2 (de) | 2002-04-03 |
| WO2001002050A3 (en) | 2002-01-10 |
| NO20020056L (no) | 2002-01-07 |
| EP1191894B1 (de) | 2007-11-14 |
| DE60037116D1 (de) | 2007-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL147201A0 (en) | Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response | |
| DE60040698D1 (de) | Stimulationssystem | |
| NO996229D0 (no) | Heparanase spesifikke molekylaere prober og deres anvendelse i forskning og medisin | |
| SE8105081L (sv) | System for behovsbaserad administration av insulin | |
| DE60011274D1 (de) | Verfahren, reagenz und messkartusche zur bestimmung der gerinnungszeit | |
| TW365526B (en) | Relaxation aiding device and biological feedback aiding device | |
| DE69802428D1 (de) | Verfahren und gerät zur verminderung von alarmmisständen | |
| WO2003011215A3 (en) | Method and system to determine revised dosage | |
| BR0017048A (pt) | Pró-drogas de bisamidato fosfonato | |
| DE59009462D1 (de) | Implantierbare Vorrichtung zur dosierten Abgabe von Medikamenten in den menschlichen Körper. | |
| WO2002082972A3 (en) | Method and apparatus to optimize drug therapy | |
| DE69925957D1 (de) | Vorrichtung zur pulsartigen Verabreichung von Stickoxid mit genauer Dosis sowie Überwachunggerät und Alarmanlagen | |
| CY1107640T1 (el) | Μεθοδος για πιστοποιηση παραγοντων για τη θεραπεια διαβητη | |
| DE69333641D1 (de) | Methode zur messung der knochenresorption | |
| ATE132757T1 (de) | Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit | |
| EP1162457A3 (de) | Vielfach-Koagulationstestsystem und Verfahren zu seiner Anwendung | |
| DE69718169D1 (de) | Test zur diagnose von schizophrenie mittels niacin | |
| PT87997A (pt) | Processo para a preparacao de composicoes farmaceuticas uteis para a correccao de vias metabolicas aberrantes associadas com ciclos de crescimento descontrolados de celulas tumorais e de virus contendo arn de dupla cadeia | |
| DK0568554T3 (da) | Fremgangsmåde til påvisning af anti-RNA-antistoffer | |
| ES2095337T3 (es) | Preparacion de pranoprofen de liberacion sostenida. | |
| FI973424L (fi) | Menetelmä ja järjestelmä potilasvalvonnan yhteydessä | |
| ATE126437T1 (de) | Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf. | |
| ES2077698T3 (es) | Agente terapeutico para la gangrena diabetica. | |
| EA200100539A1 (ru) | Новый способ лечения | |
| DUPEU | The sterilizing action of a gaseous formol: Use of a chamber equipped with a ventilation system |